Valuation (26%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 13.95 |
| PEG Ratio (TTM) | N/A | -2.45 |
| P/S Ratio (TTM) | 2.19 | 2.55 |
| P/B Ratio (TTM) | N/A | 1.81 |
| P/FCF Ratio (TTM) | N/A | 26.21 |
| Price to 5YR AVG Earnings Ratio | 0.70 | 16.86 |
| Price to 5YR AVG FCF Ratio | 133.57 | 32.44 |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.17% | 5.68% |
| ROE (TTM) | 24.20% | 14.00% |
| Net Profit Margin (TTM) | 22.94% | 19.21% |
| ROIC 5YR AVG | 41.67% | 3.17% |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 32.71% | 174.23% | 133.29% |
| Revenue | 2.82% | 19.75% | 17.90% |
| Net Income | 32.76% | 26.56% | 40.55% |
| Cash Flow | N/A | -119.78% | -38.95% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 18.58 | 6.69 |
| Quick Ratio (TTM) | 18.58 | 6.97 |
| D/E Ratio (TTM) | N/A | 0.26 |
| Interest Coverage (TTM) | N/A | 9.66 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 2.19 | 2.56 |
| LTL to 5YR AVG FCF | N/A | 4.19 |
| Shares Outstanding Growth 5YR AVG | 8.95% | -2.27% |